disease-development Downloads
11 downloads found
The use of the latest high-throughput technologies such as miRNA microarray and miRNA-Seq allows further in-depth research on the mechanism of miRNA functions. CD Genomics excels in providing a comprehensive portfolio of sequencing services. Our miRNA-Seq and miRNA microarray will help you study the role of miRNAs in cell differentiation, biological development, disease development, and beyond. ...
The use of the latest high-throughput technologies, such as miRNA microarrays and miRNA-Seq, allows further in-depth research on the mechanism by which miRNA functions. CD Genomics excels at providing a comprehensive portfolio of sequencing services. Our miRNA-Seq and miRNA microarray will help you study the role of miRNAs in cell differentiation, biological development, disease development, and ...
Originally developed for in-house testing, the company’s Advanced peripheral blood Hematopoietic Chimera (“ApbHC”) is a novel type of humanised mouse that presents several advantages over existing mouse models. It has applications for disease modelling and drug development, and potentially for ...
Based on rich experience in targeted sequencing, CD Genomics has developed a Disease Panel platform for targeted sequencing of disease-related genes to help researchers with cancer diagnostics and analysis, pathogen detection, and pharmacogenomics testing. ...
TCR profiling holds great potential not only for understanding the mechanisms of development of the normal immune response, but also in providing insights into disease mechanisms and development of new therapeutics and treatment modalities in infectious diseases, autoimmunity and in immuno-oncology. However, identification of all potential clonotypes in a diverse repertoire of TCRs requires ...
The relative inaccessibility of human brain tissues has largely hampered the understanding of human neurological diseases and impeded drug development. ...
People with rare diseases often wait years to receive a proper diagnosis and many never receive one at all. RARE ANSWERS™ is a system of innovative and sustainable tools designed to help shorten the diagnostic journey and time to initiating treatment of children with a rare disease. Developed in collaboration with leading children’s hospitals and technology and data-science ...
Targeted and non-targeted metabolomics take part in food identification, disease research, animal model verification, biomarker discovery, disease diagnosis, drug development, drug screening, drug evaluation, clinical research, plant metabolism research, and microbial metabolism research. ...
In diagnostics laboratories, molecular tests are integrated into standard practice for identifying and managing disease, predicting the risk of developing disease or recurrence, and informing decisions that help guide lifestyle choices and behaviors. These tests have become indispensable tools, both in the practice of medicine and in the quest to positively impact patient outcomes. The use of ...
Targeted and non-targeted metabolomics take part in food identification, disease research, animal model verification, biomarker discovery, disease diagnosis, drug development, drug screening, drug evaluation, clinical research, plant metabolism research, and microbial metabolism research. ...
When we identify a successful compound, we aim to develop it for both the rare disease and broader indications, further improving healthcare through innovative treatments.An example is Muckle-Wells syndrome, a rare disease that can have potentially fatal complications. ...